You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

Returns | 1W : -2.3% , 1M : 22.9%,1Y : 302.1%
BOM : 507789     NSE : JAGSNPHARM    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
May 14,2021
Price(EOD): Rs. 95.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 249.16 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
JAGSONPAL PHARMACEUTICALS -2.3% 22.9% 302.1%
SUN PHARMACEUTICAL INDUSTRIES 1.7% 11.6% 51.5%
DR REDDYS LABORATORIES 0.4% 4.1% 40.6%
DIVIS LABORATORIES -0.2% 6.3% 71.8%
CIPLA 2.4% 0.1% 57.7%
BIOCON 2.1% -3.8% 12.2%
AUROBINDO PHARMA -0.6% 9.9% 47.1%
LUPIN -1.4% 12.7% 42.7%
TORRENT PHARMACEUTICALS 4.1% 6.5% 11.5%


FUNDAMENTAL ANALYSIS OF JAGSONPAL PHARMACEUTICALS

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than JAGSONPAL PHARMACEUTICALS Premium


VALUATION OF JAGSONPAL PHARMACEUTICALS

 
Valuation Score
Ratio Standalone
P/E
P/B
P/S
31.7
P/E Calculated based on EPS of 3
[ Mar2020 - Standalone Results ]

2.41
P/B Calculated based on Book Value of 39.39
[ Mar2020 - Standalone Results ]

1.72
P/S Calculated based on Revenues of 144.986 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than JAGSONPAL PHARMACEUTICALS Premium


FAIR VALUE OF JAGSONPAL PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
272%
138%
384%

SHARE PRICE MOMENTUM OF JAGSONPAL PHARMACEUTICALS

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.05
0.04
0.09
0.06
-
-
-
-
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Mar2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
1.33%
34.11%
36.13%
35.56%
35.93%
152.85%
131.57%
137.93%
QtrlyTrend
8
Latest Qtr: Dec2020

JAGSONPAL PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

FAQ [Frequently Asked Questions]


Is JAGSNPHARM good for long term investment?

As on 14-May-2021, the Fundamentals of JAGSNPHARM are Poor and hence it's not good for long term investment ! See Financial Performance of JAGSONPAL PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is JAGSNPHARM UnderValued or OverValued?

As on 14-May-2021, JAGSNPHARM is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of JAGSNPHARM ?

As on 14-May-2021, the Intrinsic Value of JAGSNPHARM is Rs. 25.56 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 25.56
Fair Value [Median EV / Sales Model] : Rs. 39.88
Fair Value [Median Price / Sales Model] : Rs. 19.65
Median Fair Value of JAGSNPHARM : Rs. 25.56

Is JAGSNPHARM trading at a Premium or Discount?

As on 14-May-2021, JAGSNPHARM is trading at a Premium of 272% based on the Median Intrinsic Value!

Is it right time to buy JAGSNPHARM shares?

As on 14-May-2021, JAGSNPHARM is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of JAGSNPHARM?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with JAGSNPHARM?

JAGSONPAL PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
JAGSONPAL PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
JAGSONPAL PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
JAGSONPAL PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
JAGSONPAL PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
JAGSONPAL PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
JAGSONPAL PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
JAGSONPAL PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
JAGSONPAL PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z